Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT03127072
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

Who this might be right for
Colorectal Cancer Liver Metastasis
Fudan University 200
Not applicableStudy completedNCT00817895
What this trial is testing

Intraoperative Chemotherapy Against Hepatocellular Carcinoma Recurrence

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 150
Testing effectiveness (Phase 2)Study completedNCT01247337
What this trial is testing

Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma
Dorte Nielsen 56
Post-approval studies (Phase 4)UnknownNCT01438437
What this trial is testing

Trial of Ablation of Small Hepatocellular Carcinomas in Patients of Cirrhosis

Who this might be right for
Hepatocellular Carcinoma
All India Institute of Medical Sciences 54
Not applicableLooking for participantsNCT04410302
What this trial is testing

Patient-Derived Xenografts to Reduce Cancer Health Disparities

Who this might be right for
Bladder CarcinomaGastric CarcinomaLiver and Intrahepatic Bile Duct Carcinoma+2 more
University of California, Davis 500
Early research (Phase 1)Ended earlyNCT01907802
What this trial is testing

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Who this might be right for
BRAF Gene MutationHepatic ComplicationRenal Failure+1 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)Study completedNCT00464295
What this trial is testing

Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC)

Who this might be right for
Carcinoma, Hepatocellular
Aga Khan University 15
Early research (Phase 1)Study completedNCT02354898
What this trial is testing

BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Sumitomo Pharma Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT05692024
What this trial is testing

COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER

Who this might be right for
Colorectal CancerCoffeeGastrointestinal Microbiome+4 more
Massachusetts General Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT07398326
What this trial is testing

Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Shanghai Changzheng Hospital 37
Not applicableLooking for participantsNCT04796818
What this trial is testing

An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the LiverResectable Colorectal Carcinoma+4 more
M.D. Anderson Cancer Center 70
Not applicableActive Not RecruitingNCT05267080
What this trial is testing

Registry on Percutaneous Electrochemotherapy

Who this might be right for
Primary Liver CancerSecondary Liver Cancer
Cardiovascular and Interventional Radiological Society of Europe 250
Early research (Phase 1)UnknownNCT03734926
What this trial is testing

ZSP1241 in Participants With Advanced Solid Tumors

Who this might be right for
Hepatocellular CarcinomaCholangiocarcinomaGastric Cancer+2 more
Guangdong Zhongsheng Pharmaceutical Co., Ltd. 90
Not applicableStudy completedNCT04186260
What this trial is testing

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

Who this might be right for
NAFLD
University of Arizona 15
Not applicableStudy completedNCT03156582
What this trial is testing

Impacts of the α-fetoprotein (AFP) Score in Real Life for Patient Selection for Liver Transplantation (LT) for Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
University Hospital, Grenoble 562
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07545213
What this trial is testing

Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis

Who this might be right for
Non-small Cell Lung CancerEGFR Mutant Advanced Non-small Cell Lung Cancer
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 27
Not applicableUnknownNCT05396950
What this trial is testing

CPAP for Motion Management in Breast Radiotherapy; and Lung & Liver SABR

Who this might be right for
Cancer
Waikato Hospital 70
Not applicableStudy completedNCT02705118
What this trial is testing

Evaluation of Performance of Automatic Fusion for Radiofrequency Ablation of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
JOON-IL CHOI 82
Not applicableUnknownNCT04107324
What this trial is testing

ARAPS Study on Accelerated Liver Regeneration

Who this might be right for
Liver RegenerationLiver CancerLiver Metastases+1 more
University of Aarhus 30
Testing effectiveness (Phase 2)Ended earlyNCT03318562
What this trial is testing

A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC

Who this might be right for
Triple Negative Breast CancerHepatocellular Carcinoma
Effector Therapeutics 3
Next Page